Screener
Amrize AMRZ Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $3.49B+8.6% | $2.18B+4.4% | $2.84B-0.4% | $3.68B+6.6% | $3.22B-0.8% | ||
| $2.5B+9.8% | $1.97B+6.5% | $2.08B+0.3% | $2.59B+7.7% | $2.28B+0.6% | ||
| $993M+5.5% | $208M-12.2% | $760M-2.2% | $1.09B+4.2% | $941M-3.9% | ||
| 28.4%-0.8pp | 9.5%-1.8pp | 26.8%-0.5pp | 29.6%-0.7pp | 29.2%-0.9pp | ||
| $283M-1.0% | $285M+17.3% | $278M+6.1% | $312M+29.5% | $286M+25.4% | ||
| $711M+8.2% | -$72M-1,340% | $475M-11.5% | $778M-7.8% | $657M-12.9% | ||
| 20.3%-0.1pp | -3.3%-3.1pp | 16.7%-2.1pp | 21.2%-3.3pp | 20.4%-2.8pp | ||
| -$89M+26.4% | -$78M+33.9% | -$85M+33.6% | -$89M+31.5% | -$121M+9.7% | ||
| -$1M-200% | $2M+100% | $2M+104% | $0+100% | $1M— | ||
| $621M+15.6% | -$145M-9.0% | $392M+8.6% | $689M-2.0% | $537M-13.4% | ||
| $146M+19.7% | -$41M-46.4% | $100M+33.3% | $150M-3.2% | $122M-18.1% | ||
| $478M+14.6% | -$105M-11.7% | $298M+2.4% | $545M-1.4% | $417M-12.0% | ||
| 13.7%+0.7pp | -4.8%-0.3pp | 10.5%+0.3pp | 14.8%-1.2pp | 13%-1.7pp | ||
| $0.86+14.7% | -$0.19-11.8% | $0.54+3.8% | $0.98-2.0% | $0.75-12.8% | ||
| $968M+9.6% | $165M-23.3% | $719M-5.6% | $1.01B-5.9% | $883M-9.7% | ||
| 27.7%+0.3pp | 7.6%-2.7pp | 25.3%-1.4pp | 27.5%-3.7pp | 27.4%-2.7pp | ||
| $711M+8.2% | -$72M-1,340% | $475M-11.5% | $778M-7.8% | $657M-12.9% |
FAQ
- What is Amrize's revenue?
- Amrize (AMRZ) generated $12.2B in revenue over the trailing twelve months, up 5.1% year over year.
- Is Amrize profitable?
- Amrize reported $1.2B in net income over the trailing twelve months, a 10.0% net margin.
- What are Amrize's profit margins?
- Gross margin is 25.0% and operating margin is 15.5%, with a 10.0% net margin.
- What is Amrize's earnings per share?
- Amrize's diluted EPS over the trailing twelve months is $2.19.
- Where does Amrize's income statement data come from?
- Every line is extracted from Amrize's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
